Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/126851
Title: Cytoplasmic cyclin D1 regulates cell invasion and metastasis through the phosphorylation of paxillin
Author: Fusté, Noel P.
Fernández Hernández, Rita
Cemeli, Tània
Mirantes, Cristina
Pedraza González, Neus
Rafel, Marta
Torres Rosell, Jordi
Colomina, Neus
Ferrezuelo, Francisco
Dolcet, Xavier
Garí, Eloi
Keywords: Tumors
Metàstasi
Metastasis
Issue Date: 16-May-2016
Publisher: Nature Publishing Group
Abstract: Cyclin D1 (Ccnd1) together with its binding partner Cdk4 act as a transcriptional regulator to control cell proliferation and migration, and abnormal Ccnd1 . Cdk4 expression promotes tumour growth and metastasis. While different nuclear Ccnd1 . Cdk4 targets participating in cell proliferation and tissue development have been identified, little is known about how Ccnd1 . Cdk4 controls cell adherence and invasion. Here, we show that the focal adhesion component paxillin is a cytoplasmic substrate of Ccnd1 . Cdk4. This complex phosphorylates a fraction of paxillin specifically associated to the cell membrane, and promotes Rac1 activation, thereby triggering membrane ruffling and cell invasion in both normal fibroblasts and tumour cells. Our results demonstrate that localization of Ccnd1 . Cdk4 to the cytoplasm does not simply act to restrain cell proliferation, but constitutes a functionally relevant mechanism operating under normal and pathological conditions to control cell adhesion, migration and metastasis through activation of a Ccnd1 . Cdk4-paxillin-Rac1 axis.
Note: Reproducció del document publicat a: https://doi.org/10.1038/ncomms11581
It is part of: Nature Communications, 2016, vol. 7
URI: http://hdl.handle.net/2445/126851
Related resource: https://doi.org/10.1038/ncomms11581
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
FusteNP.pdf2.62 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons